ARS Pharmaceuticals is a stealth pharmaceutical company with a mission to provide better protection from severe allergic reactions. Their intranasal sprays are developed with a novel nasal absorption enhancing technology to treat reactions potentially leading to anaphylaxis. They are developing ARS-1, a needle-free alternative that is easy-to-use, convenient and more reliable for patients and loved ones at risk of severe allergic reactions to food, medications, and insect bites. ARS-1 aims to provide patients and their caregivers with confidence in the effectiveness of the product and the ability to administer it, without anxiety or hesitation.